A Multinational, Multicenter, Double Blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Aerosolized Recombinant Human DNASE I in Hospitalized Patients with Chronic Obstructive Pulmonary Disease Experiencing a Pulmonary Exacerbation,
Role: PI,
LLU Dept. of Medicine,
(07/1995 - 07/1996)
Status: Completed